Forbes March 26, 2020
In the throes of a full COVID-19 pandemic, most business leaders’ top priority is rightfully the health and safety of their employees, families, and communities. Even though business disruptions are significant and overwhelming, the primary efforts focused on both safety and the control of the spread of SARS-CoV-2, like social distancing and working remotely, are paramount.
Without diminishing the importance of those priorities, business leaders also need to think about the viability of their organizations and rapidly embrace strategic planning around the crisis. For biotech leaders, this involves strengthening efforts aimed at mitigating the negative consequences of the pandemic on the advancement of the industry’s pipeline of new medicines. Before addressing those issues, it’s important to put the economic changes...
Today's Sponsors
Today's Sponsor